- Home
- IVP vs PBM Comparison
IVP vs PBM Comparison
Compare IVP & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- PBM
- Stock Information
- Founded
- IVP 2020
- PBM 1994
- Country
- IVP United States
- PBM Canada
- Employees
- IVP N/A
- PBM N/A
- Industry
- IVP Diversified Commercial Services
- PBM
- Sector
- IVP Miscellaneous
- PBM
- Exchange
- IVP Nasdaq
- PBM NYSE
- Market Cap
- IVP 3.3M
- PBM 3.0M
- IPO Year
- IVP 2023
- PBM N/A
- Fundamental
- Price
- IVP $0.97
- PBM $5.12
- Analyst Decision
- IVP
- PBM
- Analyst Count
- IVP 0
- PBM 0
- Target Price
- IVP N/A
- PBM N/A
- AVG Volume (30 Days)
- IVP 74.7K
- PBM 48.4K
- Earning Date
- IVP 08-13-2025
- PBM 07-22-2025
- Dividend Yield
- IVP N/A
- PBM N/A
- EPS Growth
- IVP N/A
- PBM N/A
- EPS
- IVP N/A
- PBM 5.24
- Revenue
- IVP $15,399,751.00
- PBM N/A
- Revenue This Year
- IVP N/A
- PBM N/A
- Revenue Next Year
- IVP N/A
- PBM N/A
- P/E Ratio
- IVP N/A
- PBM $0.95
- Revenue Growth
- IVP N/A
- PBM N/A
- 52 Week Low
- IVP $0.90
- PBM $2.93
- 52 Week High
- IVP $401.50
- PBM $701.82
- Technical
- Relative Strength Index (RSI)
- IVP 24.79
- PBM 51.94
- Support Level
- IVP $1.58
- PBM $4.86
- Resistance Level
- IVP $1.76
- PBM $5.69
- Average True Range (ATR)
- IVP 0.14
- PBM 0.36
- MACD
- IVP -0.07
- PBM -0.02
- Stochastic Oscillator
- IVP 7.85
- PBM 51.59
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.